Company Filing History:
Years Active: 1978-1979
Title: The Innovative Contributions of Sharon G Willer
Introduction
Sharon G Willer is a notable inventor based in Loveland, Ohio, recognized for her significant contributions to the field of dermatological science. With a total of five patents to her name, she has made strides in developing methods to alleviate skin irritation caused by allergic reactions. Her work is particularly relevant in today's world, where contact dermatitis is a common issue faced by many individuals.
Latest Patents
One of her latest patents focuses on a method of inhibiting skin irritation. This innovative approach addresses the irritation resulting from allergic contact dermatitis, which can be triggered by both natural and synthetic allergenic agents, such as poison ivy and dinitrochlorobenzene. The method involves applying a protective agent to the skin, which is an organic compound containing at least two polar groups, such as carboxyl groups. These groups are separated by a chain of at least 15 atoms, predominantly carbon, and may include a cyclic moiety of at least five atoms. This protective agent can be combined with a pharmacologically acceptable base for effective application to the skin prior to exposure to allergenic agents.
Career Highlights
Sharon G Willer has established herself as a key figure in her field through her innovative research and development efforts. Her work at Cincinnati Milacron Inc. has allowed her to collaborate with other talented professionals, further enhancing her contributions to dermatological solutions.
Collaborations
Some of her notable coworkers include Paul R Yust and Ralph Kelly, who have worked alongside her in various projects aimed at improving skin health and reducing irritation.
Conclusion
Sharon G Willer's innovative methods and dedication to her work have made a significant impact in the field of dermatology. Her patents reflect her commitment to finding effective solutions for skin irritation, benefiting many individuals who suffer from allergic reactions.